Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX PS DDS for Persistent Macular Edema
NCT00035906Phase 2Completed
- Sponsor
- Allergan
- Start
- Oct 2001
- Primary completion
- Aug 2004
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ozurdex in macular edema, sponsored by Allergan. Started Oct 2001; status: completed.
02
Drugs
ozurdex
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00035906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035906.